CDC’s Abortion numbers for 2021 show slight increase

By Randall K. O’Bannon, Ph.D., NRL Director of Education & Research Though it might seem somewhat anticlimactic after some other national groups have released data on the number of abortions since Dobbs, the U.S. Centers for Disease Control (CDC) has kept to its own organizational schedule and issued its report on abortions that took place in …

Continue reading "CDC’s Abortion numbers for 2021 show slight increase"

Global Study Confirms Post-Abortion Depression

By Randall K. O’Bannon, Ph.D. NRL Director of Education & Research The November 20, 2023, headline from Psychiatry Advisor made me think I’d found something: “Over One-Third of Women With an Abortion History Experience Depression.” As I looked at the study more closely, though, I determined that I had, but just not what the authors and reporters …

Continue reading "Global Study Confirms Post-Abortion Depression"

Where we stand with Pharmacy Distribution of Abortion Pills: An Update

By Randall K. O’Bannon, Ph.D., NRL Director of Education & Research Editor’s note. This appears in the November edition of National Right to Life News, the “pro-life newspaper of record.” Please share with your pro-life family and friends. If you have comments, do email me at daveandrusko@gmail.com Within days of the official January 3, 2023 announcement …

Continue reading "Where we stand with Pharmacy Distribution of Abortion Pills: An Update"

How Accurate is the “We Count” Study by the Society for Family Planning that show Abortion Increases Since Dobbs?

By Randall K. O’Bannon, Ph.D. NRL Director of Education & Research In publishing data on abortions performed before and after Dobbs, the Society for Family Planning (SFP) has offered an answer to a question folks on both sides of the issue are anxious to resolve – has abortion returned to the levels we once had under Roe? …

Continue reading "How Accurate is the “We Count” Study by the Society for Family Planning that show Abortion Increases Since Dobbs?"

Where we stand with Pharmacy Distribution of Abortion Pills: An Update — Part Two of Two

By Randall K. O’Bannon, Ph.D., NRL Director of Education & Research Editor’s note. On Monday Dr. O’Bannon looked at how the Biden administration set up the pharmacy distribution system for mifepristone and some of the legal and regulatory challenges that could delay the efforts of some of the nation’s largest pharmacy chains to offer abortion …

Continue reading "Where we stand with Pharmacy Distribution of Abortion Pills: An Update — Part Two of Two"

Where we stand with Pharmacy Distribution of Abortion Pills: An Update — Part One of Two

By Randall K. O’Bannon, Ph.D., NRL Director of Education & Research Within days of the official January 3, 2023 announcement of Biden administration’s Food and Drug Administration (FDA) that pharmacies would be allowed to stock and sell abortion pills, the nation’s top three pharmacy chains – Walgreens, CVS, and Rite Aid – all announced their …

Continue reading "Where we stand with Pharmacy Distribution of Abortion Pills: An Update — Part One of Two"

Abortion Pill Cases Moving Through the Federal Courts

Will the Supreme Court Make Mifepristone Available in All Fifty States? By Randall K O’Bannon, Ph.D., NRL Director of Education & Research Editor’s note. This appears in the October edition of National Right to Life News. Please share this valuable information from the “Pro-Life Newspaper of Record” with your family and friends. By now, it is likely …

Continue reading "Abortion Pill Cases Moving Through the Federal Courts"

A New Class Ready For a New Era

By Randall K. O’Bannon, Ph.D. Academic Director, NRL Academy Editor’s note. These were Dr. O’Bannon closing remarks concluding a very successful five weeks. Fifty years after Roe and just a year after Dobbs. Your class is a unique one. Last year, it was exciting to hear that Roe had been overturned and that we were …

Continue reading "A New Class Ready For a New Era"

Mifepristone complications less than one percent?

That’s not what the data really show By Randall K. O’Bannon, Ph.D. NRL Director of Education & Research In the recent hearing at the U.S. Fifth Circuit Court on the U.S. Food and Drug Administration’s approval the abortion pill mifepristone, government lawyer Sarah Harrington claimed that “the rate of serious complications is well less than …

Continue reading "Mifepristone complications less than one percent?"

Abortion Myths That Need Dismantling: Six Week Bans Take Effect Before Many Women Know They’re Pregnant

By Randall K. O’Bannon, Ph.D., NRL Director of Education & Research It is hard to tell exactly when or where the first statement was made, but shortly after pro-lifers introduced the first “Heartbeat Bill” in 2011, pro-abortion activists began complaining that the law, if passed, would ban abortions as early as the sixth week of …

Continue reading "Abortion Myths That Need Dismantling: Six Week Bans Take Effect Before Many Women Know They’re Pregnant"

How do you respond to those who say that taking mifepristone is “safer than taking Tylenol”?

Editor’s note. Chemical abortions [“medication abortions”] now account for the deaths of over 50% of the babies lost to abortion. There are many reasons for the huge increase but likely at the top is the blatant lie that “medication abortions” are “safe” and, indeed, “safer than taking Tylenol.” We asked Dr. Randall K. O’Bannon, NRLC’s Director …

Continue reading "How do you respond to those who say that taking mifepristone is “safer than taking Tylenol”?"